Pleiotrophin regulates serine phosphorylation and the cellular distribution of β-adducin through activation of protein kinase C

被引:58
作者
Pariser, H
Herradon, G
Ezquerra, L
Perez-Pinera, P
Deuel, TF
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA
关键词
D O I
10.1073/pnas.0505901102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Pleiotrophin (PTN) was found to regulate tyrosine phosphorylation of beta-adducin through the PTN/receptor protein tyrosine phosphatase (RPTP)beta/xi signaling pathway. We now demonstrate that PTN stimulates the phosphorylation of serines 713 and 726 in the myristoylated alanine-rich protein kinase (PK) C substrate domain of beta-adducin through activation of either PKC alpha or beta. We also demonstrate that PTN stimulates translocation of phosphoserine 713 and 726 P-adducin either to nuclei, where it associates with nuclear chromatin and with centrioles of dividing cells, or to a membrane-associated site, depending on the phase of cell growth. Furthermore, we demonstrate that PTN stimulates the degradation of beta-adducin in PTN-stimulated cells. Phosphorylation of serines 713 and 726 in beta-adducin is known to markedly reduce the affinity of p-adducin for spectrin and actin and to uncouple actin/spectrin/ beta-adducin multimeric complexes needed for cytoskeletal stability. The data thus suggest that the PTN-stimulated phosphorylation of serines 713 and 726 in beta-adducin disrupts cytoskeletal protein complexes and integrity, features demonstrated in both PTN-stimulated cells and of highly malignant cells that constitutively express the endogenous Ptn gene. The data also support the important conclusion that PTN determines the cellular location of beta-adducin phosphorylated in serines 713 and 726 and raise the possibility that beta-adducin functions in support of structure of heterochromatin and centrioles during mitosis.
引用
收藏
页码:12407 / 12412
页数:6
相关论文
共 48 条
[21]  
Jager R, 1997, INT J CANCER, V73, P537
[22]   Midkine gene and the m4 muscarinic acid receptor gene are linked on mouse chromosome 2 [J].
Kha, H ;
Li, YS ;
Deuel, TF .
GENOMICS, 1996, 37 (02) :242-244
[23]   Heparin-binding growth-associated molecule contains two heparin-binding β-sheet domains that are homologous to the thrombospondin type I repeat [J].
Kilpeläinen, I ;
Kaksonen, M ;
Kinnunen, T ;
Avikainen, H ;
Fath, M ;
Linhardt, RJ ;
Raulo, E ;
Rauvala, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (18) :13564-13570
[24]   Tyrosine phosphorylation translocates β-catenin from cell-cell interface to the cytoplasm, but does not significantly enhance the LEF-1-dependent transactivating function [J].
Kim, K ;
Lee, KY .
CELL BIOLOGY INTERNATIONAL, 2001, 25 (05) :421-427
[25]  
Klomp HJ, 2002, CLIN CANCER RES, V8, P823
[26]   Association between a transmembrane protein tyrosine phosphatase and the cadherin-catenin complex [J].
Kypta, RM ;
Su, H ;
Reichardt, LF .
JOURNAL OF CELL BIOLOGY, 1996, 134 (06) :1519-1529
[27]   MITOGENIC AND IN-VITRO ANGIOGENIC ACTIVITY OF HUMAN RECOMBINANT HEPARIN AFFIN REGULATORY PEPTIDE [J].
LAAROUBI, K ;
DELBE, J ;
VACHEROT, F ;
DESGRANGES, P ;
TARDIEU, M ;
JAYE, M ;
BARRITAULT, D ;
COURTY, J .
GROWTH FACTORS, 1994, 10 (02) :89-98
[28]   Identification of the spectrin subunit and domains required for formation of spectrin/adducin/actin complexes [J].
Li, XL ;
Bennett, V .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (26) :15695-15702
[29]   CLONING AND EXPRESSION OF A DEVELOPMENTALLY REGULATED PROTEIN THAT INDUCES MITOGENIC AND NEURITE OUTGROWTH ACTIVITY [J].
LI, YS ;
MILNER, PG ;
CHAUHAN, AK ;
WATSON, MA ;
HOFFMAN, RM ;
KODNER, CM ;
MILBRANDT, J ;
DEUEL, TF .
SCIENCE, 1990, 250 (4988) :1690-1694
[30]   Adducin is an in vivo substrate for protein kinase C: Phosphorylation in the MARCKS-related domain inhibits activity in promoting spectrin-actin complexes and occurs in many cells, including dendritic spines of neurons [J].
Matsuoka, Y ;
Li, XL ;
Bennett, V .
JOURNAL OF CELL BIOLOGY, 1998, 142 (02) :485-497